Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spectrum Pharmaceuticals (SPPI)
NASDAQ:SPPI
Holding SPPI?
Track your performance easily
SPPI Stock Chart & Stats
Day’s Range$0.97 - $1.06
52-Week Range― - ―
Previous Close$1.03
Volume5.93M
Average Volume (3M)N/A
Market Cap
$211.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.32Price Target Upside28.16% Upside
Rating ConsensusHold
Number of Analyst Covering3
Spectrum Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SPPI FAQ
What was Spectrum Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Spectrum Pharmaceuticals’s market cap?
Currently, no data Available
When is Spectrum Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Spectrum Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Spectrum Pharmaceuticals overvalued?
According to Wall Street analysts Spectrum Pharmaceuticals’s price is currently Undervalued.
Does Spectrum Pharmaceuticals pay dividends?
Spectrum Pharmaceuticals does not currently pay dividends.
What is Spectrum Pharmaceuticals’s EPS estimate?
Spectrum Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spectrum Pharmaceuticals have?
Currently, no data Available
What happened to Spectrum Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Spectrum Pharmaceuticals?
Among the largest hedge funds holding Spectrum Pharmaceuticals’s share is Sheaff Brock Investment Advisors LLC. It holds Spectrum Pharmaceuticals’s shares valued at 35K.
---
Spectrum Pharmaceuticals Stock Smart Score
Company Description
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.
---
SPPI Stock 12 Month Forecast
Average Price Target
$1.32
▲(28.16% Upside)
---